Cargando…
Caffeine Sensitizes U87-MG Human Glioblastoma Cells to Temozolomide through Mitotic Catastrophe by Impeding G2 Arrest
Temozolomide (TMZ) is the first-line chemotherapeutic agent in the treatment of glioblastoma multiforme (GBM). Despite its cytotoxic effect, TMZ also induces cell cycle arrest that may lead to the development of chemoresistance and eventual tumor recurrence. Caffeine, a widely consumed neurostimulan...
Autores principales: | Li, Ning, Zhang, Pingde, Kiang, Karrie Mei Yee, Cheng, Yin Stephen, Leung, Gilberto Ka Kit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046144/ https://www.ncbi.nlm.nih.gov/pubmed/30050935 http://dx.doi.org/10.1155/2018/5364973 |
Ejemplares similares
-
Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells
por: Zhu, Zhiyuan, et al.
Publicado: (2019) -
Long Non-Coding RNAs Dysregulation and Function in Glioblastoma Stem Cells
por: Zhang, Xiaoqin, et al.
Publicado: (2015) -
ADD3 Deletion in Glioblastoma Predicts Disease Status and Survival
por: Kiang, Karrie Mei-Yee, et al.
Publicado: (2021) -
Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR
por: Bassi, Rosaria, et al.
Publicado: (2023) -
Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
por: Filippi-Chiela, Eduardo C, et al.
Publicado: (2013)